HEPI gets PAZ patent issuance notification
The patent, titled ‘Composition and Use of Phyto-Percolate for the Treatment of Disease,’ describes the general makeup of PAZ and its ability to address a variety of common
miRecule has signed a research collaboration with EM subsidiary Rio Biofarma Brasil (RBBL) to co-develop peptide-mediated delivery technologies aimed at improving targeted ribonucleic acid (RNA) therapeutics delivery to tissues beyond the liver and muscles in a range of disease areas.
Veeva claims that its Pharma CRM solution combines complete functionality for specialty care, primary care, managed markets and KOL management in a single application, empowering teams to integrate